Eli Lilly and Company
Compounds useful for inhibiting ROR.gamma.t
Last updated:
Abstract:
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof, formula (A). ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
27 Feb 2018
Issue date:
18 May 2021